| Malignant mesothelioma diagnosis Q Arif, AN Husain Archives of pathology & laboratory medicine 139 (8), 978-980, 2015 | 94 | 2015 |
| MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma R Kanteti, I Dhanasingh, I Kawada, FE Lennon, Q Arif, R Bueno, R Hasina, ... PloS one 9 (9), e105919, 2014 | 68 | 2014 |
| Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non–small cell lung cancer I Kawada, R Hasina, Q Arif, J Mueller, E Smithberger, AN Husain, ... Cancer research 74 (3), 884-895, 2014 | 68 | 2014 |
| Amount of epithelioid differentiation is a predictor of survival in malignant pleural mesothelioma WT Vigneswaran, DY Kircheva, V Ananthanarayanan, S Watson, Q Arif, ... The Annals of Thoracic Surgery 103 (3), 962-966, 2017 | 49 | 2017 |
| Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer I Kawada, R Hasina, FE Lennon, VP Bindokas, P Usatyuk, YHC Tan, ... Cancer biology & therapy 14 (7), 679-691, 2013 | 45 | 2013 |
| Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma FE Lennon, GC Cianci, R Kanteti, JJ Riehm, Q Arif, VA Poroyko, ... Scientific reports 6 (1), 24578, 2016 | 41 | 2016 |
| O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer R Hasina, M Surati, I Kawada, Q Arif, GB Carey, R Kanteti, AN Husain, ... Journal of carcinogenesis 12, 2013 | 26 | 2013 |
| Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer CE Rolle, R Kanteti, M Surati, S Nandi, I Dhanasingh, S Yala, ... Molecular cancer therapeutics 13 (3), 576-584, 2014 | 24 | 2014 |
| EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma YHC Tan, S Srivastava, BM Won, R Kanteti, Q Arif, AN Husain, H Li, ... Oncogenesis 8 (9), 49, 2019 | 22 | 2019 |
| Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database M Surati, M Robinson, S Nandi, L Faoro, C Demchuk, CE Rolle, R Kanteti, ... Journal of clinical bioinformatics 1, 1-11, 2011 | 17 | 2011 |
| Value of lmmunohistochemical markers in differentiating benign from malignant mescithelial lesions A Aeurio, Q Arif, P Gattuso, M McIntere, T Krausz, AN Husain MODERN PATHOLOGY 21, 334A-334A, 2008 | 15 | 2008 |
| Update in nonneoplastic lung diseases IO Gordon, N Cipriani, Q Arif, AC Mackinnon, AN Husain Archives of pathology & laboratory medicine 133 (7), 1096-1105, 2009 | 13 | 2009 |
| EPHB4 as a potential therapeutic target for esophageal cancer R Hasina, K Mutreja, I Kawada, R Kanteti, Q Arif, R Liu, X Li, Y Zhou, ... Cancer Research 72 (8_Supplement), 1861-1861, 2012 | 1 | 2012 |
| Interobserver Variability in Assessing Sarcomatoid Components of Biphasic Malignant Mesothelioma (BMM): Implications for Outcome Measures V Ananthanarayanan, W Vigneswaran, D Kircheva, Q Arif, T Krausz, ... LABORATORY INVESTIGATION 96, 467A-467A, 2016 | | 2016 |
| Abstract LB-239: Inhibition of MET/RON in lung cancer R Hasina, I Kawada, Q Arif, J Mueller, AN Husain, EE Vokes, R Salgia Cancer Research 74 (19_Supplement), LB-239-LB-239, 2014 | | 2014 |
| Necrosis and Nuclear Grade Are Predictors of Overall Survival in Epithelioid Malignant Mesotheliomas (EMM) V Ananthanarayanan, S McGregor, Q Arif, D Hadi, M Alikhan, ... LABORATORY INVESTIGATION 94, 472A-472A, 2014 | | 2014 |
| Small Molecule Inhibitors of MET and Topoisomerase I Synergize to Decrease the Viability of Small Cell Lung Cancer CE Rolle, M Surati, R Hseu, R Kanteti, Q Arif, M Tretiakova, AN Husain, ... JOURNAL OF THORACIC ONCOLOGY 7 (9), S281-S281, 2012 | | 2012 |
| Paxillin Mutations and Their Potential Functions in Thoracic Cancer R Hasina, I Kawada, FE Lennon, E Smithberger, Q Arif, AN Husain, ... JOURNAL OF THORACIC ONCOLOGY 7 (9), S284-S285, 2012 | | 2012 |
| MET/RON Dual Inhibition by LY2801653 Small Molecule Inhibitor with Dramatic Effects on Non-Small Cell Lung Cancer I Kawada, R Hasina, Q Arif, J Mueller, E Smithberger, AN Husain, ... JOURNAL OF THORACIC ONCOLOGY 7 (9), S263-S264, 2012 | | 2012 |
| Abstract A37: Interim analysis of CALGB 150607: A pilot study of the mutational & expression status of MET, HGF, EGFR, KRAS, p53, c-CBL, and E-cadherin in resected lung … R Salgia, V Nallasura, RA Kratzke, EE Vokes, H Pang, CE Rolle, ... Clinical Cancer Research 18 (3_Supplement), A37-A37, 2012 | | 2012 |
Frances LennonUniversity of ChicagoVerified email at uchicago.edu
